We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
For comparability protocols, the FDA should allow for reporting categories other than Prior Approval Supplements (PASs) if tests and studies do not meet predefined acceptance criteria, PhRMA told the agency in comments on a draft guidance on the protocols.